Catalyst Conference Call Series: Syndax Pharmaceuticals (SNDX): Entinostat in Hormone Receptor-Positive Breast Cancer

At B. Riley and Co., we offer unparalleled value, proprietary research, and creative banking solutions to our clients.

Catalyst Conference Call Series: Syndax Pharmaceuticals (SNDX): Entinostat in Hormone Receptor-Positive Breast Cancer

Catalyst Conference Call Series: Syndax Pharmaceuticals (SNDX): Entinostat in Hormone Receptor-Positive Breast Cancer

Catalyst Conference Call Series: Syndax Pharmaceuticals (SNDX): Entinostat in Hormone Receptor-Positive Breast Cancer

Quick Nav
Quick Nav
Research